Associate Professor Michael Hill
Laboratory Scientific Director
- MRC PHRU Director of Laboratories
Associate Professor Mike Hill joined CTSU in 2009 and is the Laboratory Scientific Director of the NDPH Wolfson Laboratories. He has a background in population-based studies and functional studies associated with respiratory and cardiovascular disease. He manages a team of 40 research and technical staff and is responsible for senior strategic oversight of all aspects of laboratory research within NDPH.
Mike works closely with NDPH’s principal investigators, providing central laboratory support for their clinical trials and observational studies ensuring the scientific integrity of the laboratory work.
Research interests include investigating new biochemical markers and validating analytical methods suitable for large-scale research. NDPH Wolfson Laboratories are a UKAS accredited testing laboratory (ISO 17025:2017 No. 2799) with extensive computer automation and a particular expertise in developing reliable high-throughput methods of analysis in clinical chemistry and protein biomarkers.
Previous history: Mike gained his DPhil at the University of Oxford in 1992 and continued his post-doctoral studies at the Nuffield Department of Clinical Medicine, Oxford and The Wellcome Trust Centre for Human Genetics, Oxford. In 1998, he joined the Division of Medicine at University College London where he led a research group.
Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults.
Yao P. et al, (2023), Eur J Epidemiol
Genotyping and population characteristics of the China Kadoorie Biobank.
Walters RG. et al, (2023), Cell Genom, 3
Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.
Yao P. et al, (2023), Int J Epidemiol, 52, 1197 - 1208
Performance of self-collected saliva samples for SARS-CoV-2 mass testing in community settings
Kay O. et al, (2023), Journal of Clinical Virology Plus, 3
Long-Term Exposure to Fine Particulate Matter and Incidence of Esophageal Cancer: A Prospective Study of 0.5 Million Chinese Adults.
Sun D. et al, (2023), Gastroenterology, 165, 61 - 70.e5